RLYB
Rallybio Corp
NASDAQ: RLYB · HEALTHCARE · BIOTECHNOLOGY
$8.98
+1.13% today
Updated 2026-04-30
Market cap
$46.55M
P/E ratio
—
P/S ratio
54.25x
EPS (TTM)
$-1.59
Dividend yield
—
52W range
$2 – $11
Volume
0.2M
Rallybio Corp (RLYB) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Total assets | $21.61M | $141.86M | $182.19M | $180.44M | $115.62M | $68.11M | $62.26M |
| Cash & equivalents | $19.46M | $140.23M | $175.33M | $56.96M | $24.49M | $13.90M | $31.37M |
| Current assets | $20.92M | $141.26M | $180.87M | $179.50M | $114.79M | $67.84M | $61.25M |
| Total liabilities | $4.75M | $5.86M | $6.58M | $11.12M | $9.44M | $6.45M | $4.30M |
| Current liabilities | $3.81M | $5.84M | $6.55M | $10.74M | $9.26M | $6.24M | $4.22M |
| Long-term debt | — | — | — | — | — | — | — |
| Shareholder equity | $16.86M | $136.00M | $175.60M | $169.32M | $106.18M | $61.65M | $57.96M |
| Retained earnings | $-20.57M | $-47.01M | $-94.03M | $-160.68M | $-235.25M | $-293.02M | $-302.00M |
| Accounts receivable | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — |
| Goodwill | — | — | — | — | — | — | — |